In particular, 5-HT1 and 5-HT2 receptors are closely associated with aggressive tendencies of cancer cells [12,13], prompting extensive research on the inhibitory potential of 5-HT1 and 5-HT2 receptor antagonists against cancer cell growth [14,15]. Here, HTR2A is linked to cancer.